RADIOIMMUNOASSAY OF ACIPIMOX IN HUMAN-PLASMA AND URINE

被引：3

作者：

MAGGI, E

PIANEZZOLA, E

VALZELLI, G

机构：

来源：

PHARMACOLOGICAL RESEARCH COMMUNICATIONS | 1984年 / 16卷 / 11期

关键词：

D O I：

10.1016/S0031-6989(84)80072-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1081 / 1090

页数：10

共 8 条

[1]

AMBROGI V, 1980, EUR J MED CHEM, V15, P157

[2] QUANTITATIVE IMMUNOCHEMICAL MEASURE OF THE PRIMARY INTERACTION BETWEEN I-STAR-BSA AND ANTIBODY [J].

FARR, RS .

JOURNAL OF INFECTIOUS DISEASES, 1958, 103 (03) :239-262

[3]

FRAGIACOMO C, 1980, 7 INT S DRUG AFF LIP, P240

[4] INHIBITION OF LIPOLYSIS BY NICOTINIC-ACID AND BY ACIPIMOX [J].

FUCCELLA, LM ;

GOLDANIGA, G ;

LOVISOLO, P ;

MAGGI, E ;

MUSATTI, L ;

MANDELLI, V ;

SIRTORI, CR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (06) :790-795

[5] PHARMACOLOGICAL PROFILE OF A NEW ANTI-LIPOLYTIC AGENT - 5-METHYL-PYRAZINE-2-CARBOXYLIC ACID 4-OXIDE (ACIPIMOX) .1. MECHANISM OF ACTION [J].

LOVISOLO, PP ;

BRIATICOVANGOSA, G ;

ORSINI, G ;

RONCHI, R ;

ANGELUCCI, R ;

VALZELLI, G .

PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (02) :151-161

[6] PHARMACOLOGICAL PROFILE OF A NEW ANTI-LIPOLYTIC AGENT - 5-METHYL-PYRAZINE-2-CARBOXYLIC ACID 4-OXIDE (ACIPIMOX) .2. ANTI-LIPOLYTIC AND BLOOD LIPID LOWERING ACTIVITY [J].

LOVISOLO, PP ;

BRIATICOVANGOSA, G ;

ORSINI, G ;

RONCHI, R ;

ANGELUCCI, R .

PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (02) :163-174

[7] BIOAVAILABILITY AND PHARMACOKINETICS IN MAN OF ACIPIMOX, A NEW ANTI-LIPOLYTIC AND HYPOLIPEMIC AGENT [J].

MUSATTI, L ;

MAGGI, E ;

MORO, E ;

VALZELLI, G ;

TAMASSIA, V .

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (05) :381-386

[8] REDUCED TRIGLYCERIDEMIA AND INCREASED HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS AFTER TREATMENT WITH ACIPIMOX, A NEW INHIBITOR OF LIPOLYSIS [J].

SIRTORI, CR ;

GIANFRANCESCHI, G ;

SIRTORI, M ;

BERNINI, F ;

DESCOVICH, G ;

MONTAGUTI, U ;

FUCCELLA, LM ;

MUSATTI, L .

ATHEROSCLEROSIS, 1981, 38 (3-4) :267-271

← 1 →